doi:

DOI: 10.3724/SP.J.1008.2011.00224

Academic Journal of Second Military Medical University (第二军医大学学报) 2011/31:2 PP.224-226

Relationship of low- and high-density lipoprotein cholesterol with atherosclerosis


Abstract:

Key words:

ReleaseDate:2014-07-21 15:47:50



[1] Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)[J].Lancet,1994,344:1383-1389.

[2] Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group[J].N Engl J Med,1998,339:1349-1357.

[3] Downs J R,Clearfield M,Weis S,Whitney E,Shapiro D R,Beere P A,et al.Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS.Air Force/Texas Coronary Atherosclerosis Prevention Study[J].JAMA,1998,279:1615-1622.

[4] Nakamura H,Arakawa K,Itakura H,Kitabatake A,Goto Y,Toyota T,et al.Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial[J].Lancet,2006,368:1155-1163.

[5] Cannon C,Braunwald E,McCabe C,Rader D,Rouleau J,Belder R,et al.Intensive versus moderate lipid lowering with statins after acute coronary syndromes[J].New Engl J Med,2004,350:1495-1504.

[6] Waters D,Guyton J,Herrington D,McGowan M,Wenger N,Shear C.Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit[J]? Am J Cardiol,2004,93:154-158.

[7] Gordon T,Castelli W P,Hjortland M C,Kannel W B,Dawber T R.High density lipoprotein as a protective factor against coronary heart disease: The Framingham study[J].Am J Med,1977,62:707-714.

[8] Miller N E,Thelle D S,Forde O H,Mjos O D.The Troms heart-study.High-density lipoprotein and coronary heart-disease: a prospective case-control study[J].Lancet,1977,309:965-968.

[9] Barter P,Gotto A M,LaRosa J C,Maroni J,Szarek M,Grundy S M,et al.HDL cholesterol,very low levels of LDL cholesterol,and cardiovascular events[J].New Engl J Med,2007,357:1301-1310.

[10] Matsuzaki M,Kita T,Mabuchi H,Matsuzawa Y,Nakaya N,Oikawa S,et al.Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia[J].Circ J,2002,66:1087-1095.

[11] Hsia S H,Pan D,Berookim P,Lee M L.A population-based,cross-sectional comparison of lipid-related indexes for symptoms of atherosclerotic disease[J].Am J Cardiol,2006,98:1047-1052.

[12] Ingelsson E,Schaefer E J,Contois J H,McNamara J R,Sullivan L,Keyes M J,et al.Clinical utility of different lipid measures for prediction of coronary heart disease in men and women[J].JAMA,2007,298:776-785.

[13] Kastelein J J,van der Steeg W A,Holme I,Gaffney M,Cater N B,Barter P,et al.Lipids,apolipoproteins,and their ratios in relation to cardiovascular events with statin treatment[J].Circulation,2008,117:3002-3009.

[14] Kinosian B,Glick H,Garland G.Cholesterol and coronary heart disease: predicting risks by levels and ratios[J].Ann Intern Med,1994,121:641-647.

[15] Riley W A.Cardiovascular risk assessment in individual patients from carotid intimal-medial thickness measurements[J].Curr Atheroscler Rep,2004,6:225-231.

[16] Amarenco P,Goldstein L B,Callahan A 3rd,Sillesen H,Hennerici M G,O’Neill B J,et al.Baseline blood pressure,low-and high-density lipoproteins,and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial[J].Atherosclerosis,2009,204:515-520.

[17] Phan B A,Chu B,Polissar N,Hatsukami T S,Yuan C,Zhao X Q.Association of high-density lipoprotein levels and carotid atherosclerotic plaque characteristics by magnetic resonance imaging[J].Int J Cardiovasc Imaging,2007,23:337-342.